PetMed Express, Inc.
PETS
$3.40
-$0.09-2.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -23.57% | -22.70% | -21.95% | -18.88% | -18.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -23.57% | -22.70% | -21.95% | -18.88% | -18.25% |
| Cost of Revenue | -18.64% | -22.03% | -21.90% | -19.73% | -22.90% |
| Gross Profit | -33.87% | -24.34% | -22.02% | -16.63% | -6.43% |
| SG&A Expenses | 6.39% | 49.98% | 20.38% | -28.22% | -6.90% |
| Depreciation & Amortization | 37.39% | 32.66% | 9.45% | -10.40% | -3.21% |
| Other Operating Expenses | -- | -- | -8.27% | -- | -- |
| Total Operating Expenses | -9.90% | -5.75% | -3.91% | -21.87% | -18.44% |
| Operating Income | -932.21% | -243.78% | -502.07% | 85.36% | -3.37% |
| Income Before Tax | -1,020.11% | -824.60% | -71.90% | 90.85% | -27.73% |
| Income Tax Expenses | 100.64% | -99.06% | 268.62% | 175.24% | -347.96% |
| Earnings from Continuing Operations | -466.29% | -1,009.75% | -132.14% | 65.12% | 225.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -466.29% | -1,009.75% | -132.14% | 65.12% | 225.31% |
| EBIT | -932.21% | -243.78% | -502.07% | 85.36% | -3.37% |
| EBITDA | -293.76% | -169.86% | -771.99% | 187.12% | -3.27% |
| EPS Basic | -461.29% | -999.18% | -129.91% | 65.42% | 221.65% |
| Normalized Basic EPS | -683.16% | -233.14% | -613.31% | 90.98% | -5.79% |
| EPS Diluted | -472.73% | -1,016.67% | -126.13% | 65.70% | 266.67% |
| Normalized Diluted EPS | -694.28% | -235.97% | -613.31% | 90.98% | -5.66% |
| Average Basic Shares Outstanding | 1.41% | 1.18% | 0.95% | 1.03% | 1.05% |
| Average Diluted Shares Outstanding | -0.24% | -0.89% | 0.95% | 1.03% | 0.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.08% | -1.00% | 0.88% | 0.81% | -1.00% |